Targeting polyamines and biogenic amines by green tea epigallocatechin-3- gallate

Amino Acids

Volumn 38, Issue 2, 2010, Pages 519-523

  Melgarejo, Esther ^a,b   Urdiales, José Luis ^a,b   Sánchez Jiménez, Francisca ^a,b   Medina, Miguel Ángel ^a,b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

DDC; EGCG; HDC; Histamine; ODC; Polyamine; SSAT; Tea

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; BIOGENIC AMINE; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; HISTAMINE; HISTIDINE DECARBOXYLASE; ORNITHINE DECARBOXYLASE; POLYAMINE; PUTRESCINE; SPERMIDINE; CATECHIN; DRUG DERIVATIVE; PLANT EXTRACT;

AMINO ACID METABOLISM; ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CELL METABOLISM; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; FUNCTIONAL GENOMICS; HISTAMINE METABOLISM; HUMAN; METABOLIC REGULATION; NONHUMAN; PLEIOTROPY; POLYAMINE METABOLISM; PRIORITY JOURNAL; PROTEIN TARGETING; TEA; ANIMAL; BIOSYNTHESIS; CHEMISTRY; REVIEW;

ANIMALS; BIOGENIC AMINES; BIOGENIC POLYAMINES; BIOSYNTHETIC PATHWAYS; CAMELLIA SINENSIS; CATECHIN; HUMANS; PLANT EXTRACTS; TEA;

EID: 77953057381     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-009-0411-z     Document Type: Conference Paper

References (47)

1. Albrecht DS, Clubbs EA, Ferruzzi M, Bomser JA (2008) Epigallocatechin-3- gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation. Chem Biol Interact 171:89-95
2. Bachrach U, Wang YC (2002) Cancer therapy and prevention by green tea: role of ornithine decarboxylase. Amino Acids 22:1-13
3. Beaven M (1978) Histamine. Its role in physiological and pathological processes. Monographs in allergy, vol 13. S. Karger AG, Basel
4. Bertoldi M, Gonsalvi M, Voltattorni CB (2001) Green tea polyphenols: novel irreversible inhibitors of dopa decarboxylase. Biochem Biophys Res Commun 284:90-93
5. Brotchie J, Fitzer-Attas C (2009) Mechanisms compensating for dopamine loss in early Parkinson disease. Neurology 72: S32-S38
6. Brown NJ, Roberts II (2001) The pharmaceutical basis of therapeutics. In: Hardman JG, Limbird LE, Gilman AG (eds) Histamine, bradykinin, and their antagonists, 10th edn. McGraw Hill, New York, pp 645-668
7. Cabrera C, Artacho R, Giménez R (2006) Beneficial effects of green tea-a review. J Am Coll Nutr 25:79-99
8. Casero RA, Pegg AE (2009) Polyamine catabolism and disease. Biochem J 421:323-338
9. Chaves P, Correa-Fiz F, Melgarejo E, Urdiales JL, Medina MA, Sánchez-Jiménez F (2007) Development of an expression macroarray for amine metabolism-related genes. Amino Acids 33:315-322
10. Cohen SS (1998) A guide to the polyamines. Oxford University Press, Oxford
11. Correa-Fiz A M F, Reyes-Palomares A, Ruiz-Pérez MV, Medina MA, Sánchez-Jiménez F (2009) Roles of biogenic amines in emergent and rare diseases. In: Dandrifosse G (ed) Biological aspects of biogenic amines, polyamines and conjugates. Transworld Research Network, Kerala, India, pp 399-419
12. Cowen PJ (2008) Serotonin and depression: pathophysiological mechanism or marketing myth? Trends Pharmacol Sci 29:433-436
13. Facchini A, Zanella B, Stefanelli C, Guarnieri C, Flamigni F (2003) Effect of green tea extract on the induction of ornithine decarboxylase and the activation of extracellular signal-regulated kinase in bladder carcinoma ECV304 cells. Nutr Cancer 47:104-110
14. Fajardo I, Urdiales JL, Medina MA, Sánchez-Jiménez F (2001a) Effects of phorbol ester and dexamethasone treatment on histidine decarboxylase and ornithine decarboxylase in basophilic cells. Biochem Pharmacol 61:1101-1106
15. Fajardo I, Urdiales JL, Paz JC, Chavarría T, Sánchez- Jiménez F, Medina MA (2001b) Histamine prevents polyamine accumulation in mouse C57.1 mast cell cultures. Eur J Biochem 268:768-773
16. García-Faroldi G, Correa-Fiz F, Abrighach H, Berdasco M, Fraga MF, Esteller M, Urdiales JL, Sánchez-Jiménez F, Fajardo I (2009) Polyamines affect histamine synthesis during early stages of IL-3-induced bone marrow cell differentiation. J Cell Biochem 108:261-271
17. Graham HN (1992) Green tea composition, consumption, and polyphenol chemistry. Prev Med 21:334-350
18. Gupta S, Hussain T, Mukhtar H (2003) Molecular pathway for (-) - epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410:177-185
19. Ho YC, Yang SF, Peng CY, Chou MY, Chang YC (2007) Epigallocatechin-3- gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. J Oral Pathol Med 36:588-593
20. Hong J, Smith TJ, Ho CT, August DA, Yang CS (2001) Effects of purified green and black tea polyphenols on cyclooxygenase-and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol 62:1175-1183
21. Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E (1997) Why drinking green tea could prevent cancer. Nature 387:561
22. Katiyar SK, Mukhtar H (1997) Tea antioxidants in cancer chemoprevention. J Cell Biochem Suppl 27:59-67
23. Kuo PL, Lin CC (2003) Green tea constituent (-)-epigallocatechin-3- gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways. J Biomed Sci 10:219-227
24. Medina MA, Urdiales JL, Rodríguez-Caso C, Ramírez FJ, Sánchez-Jiménez F (2003) Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications. Crit Rev Biochem Mol Biol 38:23-59
25. Medina MA, Correa-Fiz F, Rodríguez-Caso C, Sánchez- Jiménez F (2005) A comprehensive view of polyamine and histamine metabolism to the light of new technologies. J Cell Mol Med 9:854-864
26. Melgarejo E, Medina MA, Sánchez-Jiménez F, Botana LM, Dominguez M, Escribano L, Orfao A, Urdiales JL (2007) (-) - Epigallocatechin-3- gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes. Cell Mol Life Sci 64:2690-2701
27. Melgarejo E, Medina MA, Sánchez-Jiménez F, Urdiales JL (2009) Epigallocatechin gallate reduces human monocyte mobility and adhesion capabilities. Br J Pharmacol. doi:10.1111/j.1476-5381.2009.00452.x
28. Montañez R, Sánchez-Jiménez F, Aldana-Montes JF, Medina MA (2007) Polyamines: metabolism to systems biology and beyond. Amino Acids 33:283-289
29. Montañez R, Rodríguez-Caso C, Sánchez-Jiménez F, Medina MA (2008) In silico analysis of arginine catabolism as a source of nitric oxide or polyamines in endothelial cells. Amino Acids 34:223-229
30. Moya-García AA, Medina MA, Sánchez-Jiménez F (2005) Mammalian histidine decarboxylase: from structure to function. Bioessays 27:57-63
31. Moya-García AA, Ruiz-Pernia J, Marti S, Sánchez- Jiménez F, Tunon I (2008) Analysis of the decarboxylation step in mammalian histidine decarboxylase. A computational study. J Biol Chem 283:12393-12401
32. Moya-García AA, Pino-Ángeles A, Gil-Redondo R, Morreale A, Sanchez-Jimenez F (2009) Structural features of mammalian histidine decarboxylase reveal the basis for specific inhibition. Br J Pharmacol 157:4-13
33. Nitta Y, Kikuzaki H, Ueno H (2007) Food components inhibiting recombinant human histidine decarboxylase activity. J Agric Food Chem 55:299-304
34. Olmo MT, Urdiales JL, Pegg AE, Medina MA, Sanchez-Jimenez F (2000) In vitro study of proteolytic degradation of rat histidine decarboxylase. Eur J Biochem 267:1527-1531
35. Olmo MT, Sánchez-Jiménez F, Medina MA, Hayashi H (2002) Spectroscopic analysis of recombinant rat histidine decarboxylase. J Biochem 132:433-439
36. Paul B, Hayes CS, Kim A, Athar M, Gilmour SK (2005) Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice. Carcinogenesis 26:119-124
37. Paz JC, Sánchez-Jiménez F, Medina MA (2001) Characterization of spermine uptake by Ehrlich tumour cells in culture. Amino Acids 21:271-279
38. Peng G, Dixon DA, Muga SJ, Smith TJ, Wargovich MJ (2006) Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog 45:309-319
39. Rodríguez-Caso C, Rodríguez-Agudo D, Moya-García AA, Fajardo I, Medina MA, Subramaniam V, Sánchez-Jiménez F (2003a) Local changes in the catalytic site of mammalian histidine decarboxylase can affect its global conformation and stability. Eur J Biochem 270:4376-4387
40. Rodríguez-Caso C, Rodríguez-Agudo D, Sánchez- Jiménez F, Medina MA (2003b) Green tea epigallocatechin-3-gallate is an inhibitor of mammalian histidine decarboxylase. Cell Mol Life Sci 60:1760-1763
41. Rodríguez-Caso C, Montañez R, Cascante M, Sánchez-Jiménez F, Medina MA (2006) Mathematical modeling of polyamine metabolism in mammals. J Biol Chem 281:21799-21812
42. Roy AM, Baliga MS, Katiyar SK (2005) Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol Cancer Ther 4:81-90
43. Tipoe GL, Leung TM, Hung MW, Fung ML (2007) Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets 7:135-144
44. Urdiales JL, Medina MA, Sánchez-Jiménez F (2001) Polyamine metabolism revisited. Eur J Gastroenterol Hepatol 13:1015-1019
45. Wang YC, Bachrach U (2002) The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG). Amino Acids 22:131-143
46. Wolter F, Turchanowa L, Stein J (2003) Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos. Carcinogenesis 24:469-474
47. Yamashita K, Suzuki Y, Matsui T, Yoshimaru T, Yamaki M, Suzuki-Karasaki M, Hayakawa S, Shimizu K (2000) Epigallocatechin gallate inhibits histamine release from rat basophilic leukemia (RBL-2H3) cells: role of tyrosine phosphorylation pathway. Biochem Biophys Res Commun 274:603-608